tiprankstipranks
Trending News
More News >
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
India Market

Suven Pharmaceuticals Ltd. (SUVENPHAR) Income Statement

Compare
2 Followers

Suven Pharmaceuticals Ltd. Income Statement

Last quarter (Q3 2025), Suven Pharmaceuticals Ltd.'s total revenue was ₹3.07B, an increase of 39.73% from the same quarter last year. In Q3, Suven Pharmaceuticals Ltd.'s net income was ₹828.80M. See Suven Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 10.51B₹ 13.40B₹ 12.90B₹ 9.80B₹ 8.07B
Gross Profit
₹ 6.01B₹ 7.55B₹ 7.35B₹ 5.60B₹ 4.82B
Operating Expenses
₹ 1.40B₹ 2.36B₹ 1.92B₹ 1.48B₹ 1.21B
Depreciation and Amortization
₹ 545.96M₹ 477.32M₹ 390.97M₹ 316.36M₹ 235.07M
EBITDA
₹ 4.68B₹ 6.20B₹ 6.74B₹ 4.57B₹ 4.00B
Operating Income
₹ 4.61B₹ 5.19B₹ 5.42B₹ 4.10B₹ 3.58B
Other Income/Expenses
₹ -550.93M₹ -706.22M₹ 342.03M₹ -153.90M₹ -114.42M
Pretax Income
₹ 4.06B₹ 5.60B₹ 6.68B₹ 4.68B₹ 4.05B
Net Income
₹ 3.00B₹ 4.11B₹ 4.54B₹ 3.62B₹ 3.17B
Per Share Metrics
Basic EPS
₹ 11.80₹ 16.16₹ 17.83₹ 14.23₹ 6.23
Diluted EPS
₹ 11.80₹ 16.16₹ 17.83₹ 14.23₹ 6.23
Weighted Average Shares Outstanding
254.48M 254.56M 254.56M 254.56M 509.13M
Weighted Average Shares Outstanding (Diluted)
254.56M 254.56M 254.56M 254.56M 509.13M
Currency in INR

Suven Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis